What's in B. Braun Medical SA's pipeline?

B. Braun Medical SA has 3 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with B. Braun Medical SA's portfolio?

Top competitors by shared drug class: B. Braun Melsungen AG, GWT-TUD GmbH, General University Hospital, Prague, GlaxoSmithKline, Padagis LLC.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/b-braun-medical-sa.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

B. Braun Medical SA — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

B. Braun Medical SA pipeline: 3 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Mupirocin + Chlorhexidin	Mupirocin + Chlorhexidin	marketed	Topical antibiotic combination	Bacterial isoleucyl-tRNA synthetase (mupirocin); bacterial cell membrane (chlorhexidine)	Dermatology / Infection Prevention
MCT/LCT/omega-3 (5:4:1)	MCT/LCT/omega-3 (5:4:1)	marketed	Lipid emulsion for parenteral nutrition		Nutrition support / Critical care
MCT/LCT (1:1)	MCT/LCT (1:1)	marketed	Lipid emulsion for parenteral nutrition		Nutrition support

Therapeutic area mix

Dermatology / Infection Prevention · 1
Nutrition support · 1
Nutrition support / Critical care · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

B. Braun Melsungen AG · 1 shared drug class
GWT-TUD GmbH · 1 shared drug class
General University Hospital, Prague · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Padagis LLC · 1 shared drug class
Sanofi · 1 shared drug class
Shanghai Jiao Tong University School of Medicine · 1 shared drug class
Stiefel, a GSK Company · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for B. Braun Medical SA:

Cite this brief

Drug Landscape (2026). B. Braun Medical SA — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/b-braun-medical-sa. Accessed 2026-05-16.